Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0027960 (mole)
 21,279 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Anatomical organization of the central auditory system in the mole was studied at the lower brainstem levels. The cyto-, myelo-, and chemoarchitectures were examined in Nissl, myelin, and acetylcholinesterase stained materials, and then the origins of the ascending afferents to the inferior colliculus (IC) were identified by injecting wheatgerm agglutinin conjugated to horseradish peroxidase (WGA-HRP) into the unilateral IC and processing the tissue according to the standard retrograde tracing techniques. The results indicate that the auditory nuclei and pathways in the lower brainstem of the mole conform to the basic plan common to many other mammals. Nevertheless, several characteristic features are evidenced in the present study: (1) in the cochlear nucleus (CochN), granule cell fields are very large in both the ventral (VCN) and dorsal (DCN) nuclei; among several populations of neurons, fusiform cells in the DCN, multipolar cells in the VCN and DCN, and small spherical cells in the VCN project to the IC directly, (2) in the superior olivary complex (SOC), the medial nucleus (MSO) is well developed in comparison with that in the hedgehog, the opossum, the mouse, and the rat, although the general configuration of the SOC is similar to that in those mammals, most strikingly, the MSO projects to the IC bilaterally in the mole, and (3) the nuclei of the lateral lemniscus (NLL) show a great development and consist of three well-differentiated parts of the dorsal, intermediate, and ventral nuclei. The projections from these subnuclei to the IC conform to the basic mammalian plan.
 ...
PMID:Auditory brainstem in the mole (Mogera): nuclear configurations and the projections to the inferior colliculus. 222 72

Several research groups have recently reported on markedly reduced levels of 5-hydroxymethylcytosine (5hmC) in human breast, liver, lung, pancreatic, colon, prostate, brain, and myeloid cancers. We studied benign compound nevi (BCN, n=17), dysplastic compound nevi (DCN, n=15), superficial spreading melanomas [SSM, stratified in <1 mm (n=19) and >4 mm (n=18) Breslow tumor thickness], and cutaneous metastatic disease (CMD, n=24). Immunohistochemistry included specific antibodies against 5hmC, 5-methylcytosine (5mC), and ten-eleven translocation 2 protein (TET2). Immunohistological scoring showed significantly (P<0.0001) higher median 5hmC levels in BCN and DCN than in thin SSM, thick SSM, and CMD. 5mC immunoreactivity did not differ significantly (P=0.15) between nevi and melanoma. The intensity of TET2 expression was predominantly weak but was found to be significantly (P<0.0001) more often in nevi than in thin SSM, thick SSM, and CMD. We have shown that 5hmC levels and TET2 expression are significantly reduced in advanced melanomas compared with nevi and thin melanomas. It is suggested that 5hmC and TET2 possibly play an important role in the epigenetic regulation of melanoma development and progression.
 ...
PMID:Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma. 2345 59